EUVIMEDEUVIMED entdecken
Crossref

Fibroblast-derived Extracellular Vesicles Induce Lung Cancer Progression in the Idiopathic Pulmonary Fibrosis Microenvironment

Yu Fujita iD, Shota Fujimoto, Atsushi Miyamoto iD, Reika Kaneko, Tsukasa Kadota iD, Naoaki Watanabe, Ryusuke Kizawa, Hironori Kawamoto, Junko Watanabe, Hirofumi Utsumi, Hiroshi Wakui, Shunsuke Minagawa iD und 4 weitere

American Journal of Respiratory Cell and Molecular Biology · 01.07.2023 · 69 (1) · 34-44

DOI: 10.1165/rcmb.2022-0253oc ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, online erschienen am 01.07.2023. Verfasst von Yu Fujita und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Diseases, Department of Internal Medicine. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Idiopathic Pulmonary Fibrosis, Extracellular Vesicles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a progressive aging-related lung disease associated with increased lung cancer risk. Although previous studies have shown that IPF worsens the survival of patients with lung cancer, whether IPF independently affects cancer malignancy and prognosis remains inconclusive. Extracellular vesicles (EVs) have recently emerged as active carriers of molecular biomarkers and mediators of intercellular communication in lung homeostasis and pathogenesis. EV cargo-mediated fibroblast–tumor cell communication might participate in the development and progression of lung cancer by modulating various signaling pathways. In this study, we examined the impact of lung fibroblast (LF)-derived EVs on non-small cell lung cancer (NSCLC) malignancy in the IPF microenvironment. Here, we showed that LFs derived from patients with IPF have phenotypes of myofibroblast differentiation and cellular senescence. Furthermore, we found that IPF LF-derived EVs have markedly altered microRNA compositions and exert proproliferative functions on NSCLC cells. Mechanistically, the phenotype was attributed mainly to the enrichment of miR-19a in IPF LF-derived EVs. As a downstream signaling pathway, mir-19a in IPF LF-derived EVs regulates ZMYND11-mediated c-Myc activation in NSCLC, potentially contributing to the poor prognosis of patients with NSCLC with IPF. Our discoveries provide novel mechanistic insights for understanding lung cancer progression in the IPF microenvironment. Accordingly, blocking the secretion of IPF LF-derived EV miR-19a and their signaling pathways is a potential therapeutic strategy for managing IPF and lung cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungIdiopathic Pulmonary FibrosisExtracellular VesiclesMicroRNAsHumansLungFibroblastsTumor MicroenvironmentDNA-Binding ProteinsCell Cycle ProteinsCo-Repressor Proteins

Stichwörter der Autor:innen

extracellular vesiclesfibroblastlung cancerpulmonary fibrosis

Substanzen

MicroRNAsZMYND11 protein, humanDNA-Binding ProteinsCell Cycle ProteinsCo-Repressor Proteins

Autor:innen und Institutionen

  • Division of Respiratory Diseases, Department of Internal Medicine.
  • Department of Translational Research for Exosomes, and.
  • Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan; and.
  • Division of Thoracic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.

ORCID-Profile: Yu Fujita, Atsushi Miyamoto, Tsukasa Kadota, Shunsuke Minagawa

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Fujita, Y., Fujimoto, S., Miyamoto, A., Kaneko, R., Kadota, T., Watanabe, N., Kizawa, R., Kawamoto, H., Watanabe, J., Utsumi, H., Wakui, H., Minagawa, S., Araya, J., Ohtsuka, T., Ochiya, T., & Kuwano, K. (2023). Fibroblast-derived Extracellular Vesicles Induce Lung Cancer Progression in the Idiopathic Pulmonary Fibrosis Microenvironment. American Journal of Respiratory Cell and Molecular Biology, 69(1), 34-44. https://doi.org/10.1165/rcmb.2022-0253oc

Vancouver

Fujita Y, Fujimoto S, Miyamoto A, Kaneko R, Kadota T, Watanabe N, et al. Fibroblast-derived Extracellular Vesicles Induce Lung Cancer Progression in the Idiopathic Pulmonary Fibrosis Microenvironment. American Journal of Respiratory Cell and Molecular Biology. 2023;69(1):34-44. doi:10.1165/rcmb.2022-0253oc

BibTeX
@article{Fujita2023,
  author = {Fujita, Yu and Fujimoto, Shota and Miyamoto, Atsushi and Kaneko, Reika and Kadota, Tsukasa and Watanabe, Naoaki and Kizawa, Ryusuke and Kawamoto, Hironori and Watanabe, Junko and Utsumi, Hirofumi and Wakui, Hiroshi and Minagawa, Shunsuke and Araya, Jun and Ohtsuka, Takashi and Ochiya, Takahiro and Kuwano, Kazuyoshi},
  title = {Fibroblast-derived Extracellular Vesicles Induce Lung Cancer Progression in the Idiopathic Pulmonary Fibrosis Microenvironment},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  year = {2023},
  volume = {69},
  number = {1},
  pages = {34--44},
  doi = {10.1165/rcmb.2022-0253oc}
}
Kostenlos starten →